| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | steroid hydroxylase activity | 1.28e-12 | 34 | 85 | 8 | GO:0008395 | |
| GeneOntologyMolecularFunction | arachidonate epoxygenase activity | 6.29e-10 | 24 | 85 | 6 | GO:0008392 | |
| GeneOntologyMolecularFunction | arachidonate monooxygenase activity | 1.37e-09 | 27 | 85 | 6 | GO:0008391 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen | 1.46e-09 | 49 | 85 | 7 | GO:0016712 | |
| GeneOntologyMolecularFunction | aromatase activity | 7.31e-09 | 35 | 85 | 6 | GO:0070330 | |
| GeneOntologyMolecularFunction | monooxygenase activity | 3.15e-08 | 115 | 85 | 8 | GO:0004497 | |
| GeneOntologyMolecularFunction | iron ion binding | CYP2A6 CYP2A7 CYP2A13 CYP2C19 CYP2C8 CYP2C9 CYP27A1 CYP2U1 RRM2 | 3.66e-08 | 166 | 85 | 9 | GO:0005506 |
| GeneOntologyMolecularFunction | coumarin 7-hydroxylase activity | 7.44e-08 | 3 | 85 | 3 | GO:0008389 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | CYP2A6 CYP2A7 CYP2A13 CYP2C19 CYP2C8 CYP2C9 CYP27A1 CYP2U1 KDM4E | 1.40e-07 | 194 | 85 | 9 | GO:0016705 |
| GeneOntologyMolecularFunction | heme binding | 3.04e-07 | 154 | 85 | 8 | GO:0020037 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on CH or CH2 groups | 4.03e-07 | 15 | 85 | 4 | GO:0016725 | |
| GeneOntologyMolecularFunction | tetrapyrrole binding | 4.91e-07 | 164 | 85 | 8 | GO:0046906 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor | 4.11e-06 | 8 | 85 | 3 | GO:0033695 | |
| GeneOntologyMolecularFunction | caffeine oxidase activity | 4.11e-06 | 8 | 85 | 3 | GO:0034875 | |
| GeneOntologyMolecularFunction | estrogen 16-alpha-hydroxylase activity | 1.20e-05 | 11 | 85 | 3 | GO:0101020 | |
| GeneOntologyMolecularFunction | (R)-limonene 6-monooxygenase activity | 1.79e-05 | 2 | 85 | 2 | GO:0052741 | |
| GeneOntologyMolecularFunction | limonene monooxygenase activity | 1.79e-05 | 2 | 85 | 2 | GO:0019113 | |
| GeneOntologyMolecularFunction | (S)-limonene 6-monooxygenase activity | 1.79e-05 | 2 | 85 | 2 | GO:0018675 | |
| GeneOntologyMolecularFunction | (S)-limonene 7-monooxygenase activity | 1.79e-05 | 2 | 85 | 2 | GO:0018676 | |
| GeneOntologyMolecularFunction | retinoic acid 4-hydroxylase activity | 2.62e-05 | 14 | 85 | 3 | GO:0008401 | |
| GeneOntologyMolecularFunction | inositol 1,4,5-trisphosphate-gated calcium channel activity | 5.36e-05 | 3 | 85 | 2 | GO:0005220 | |
| GeneOntologyMolecularFunction | linoleic acid epoxygenase activity | 1.07e-04 | 4 | 85 | 2 | GO:0071614 | |
| GeneOntologyMolecularFunction | arachidonate 11,12-epoxygenase activity | 1.07e-04 | 4 | 85 | 2 | GO:0008405 | |
| GeneOntologyMolecularFunction | fatty acid omega-1 hydroxylase activity | 1.78e-04 | 5 | 85 | 2 | GO:0120502 | |
| GeneOntologyMolecularFunction | long-chain fatty acid omega-1 hydroxylase activity | 1.78e-04 | 5 | 85 | 2 | GO:0120319 | |
| GeneOntologyMolecularFunction | arachidonate 14,15-epoxygenase activity | 1.78e-04 | 5 | 85 | 2 | GO:0008404 | |
| GeneOntologyMolecularFunction | complement component C1q complex binding | 7.88e-04 | 10 | 85 | 2 | GO:0001849 | |
| GeneOntologyMolecularFunction | oxidoreductase activity | CYP2A6 CYP2A7 CYP2A13 CYP2C19 CYP2C8 CYP2C9 CYP27A1 CYP2U1 KDM4E RRM2 | 1.52e-03 | 766 | 85 | 10 | GO:0016491 |
| GeneOntologyMolecularFunction | inositol 1,4,5 trisphosphate binding | 1.58e-03 | 14 | 85 | 2 | GO:0070679 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 1.62e-03 | 118 | 85 | 4 | GO:0003774 | |
| GeneOntologyMolecularFunction | protein phosphatase binding | 2.04e-03 | 210 | 85 | 5 | GO:0019903 | |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 2.62e-03 | 18 | 85 | 2 | GO:0015278 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 3.02e-03 | 140 | 85 | 4 | GO:0099094 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 3.32e-03 | 70 | 85 | 3 | GO:0003777 | |
| GeneOntologyMolecularFunction | transition metal ion binding | CYP2A6 LIG3 CYP2A7 CYP2A13 CYP2C19 CYP2C8 CYP2C9 CYP27A1 CYP2U1 ZNFX1 RRM2 USP33 | 4.40e-03 | 1189 | 85 | 12 | GO:0046914 |
| GeneOntologyMolecularFunction | calcium ion binding | CACNA1E PCDHA10 PCDHA7 PCDHA5 PCDHA3 PCDHA2 IQGAP1 ITPR1 ITPR2 | 4.54e-03 | 749 | 85 | 9 | GO:0005509 |
| GeneOntologyMolecularFunction | ATP-dependent activity | 4.60e-03 | 614 | 85 | 8 | GO:0140657 | |
| GeneOntologyMolecularFunction | opsonin binding | 5.04e-03 | 25 | 85 | 2 | GO:0001846 | |
| GeneOntologyMolecularFunction | phosphatase binding | 5.40e-03 | 264 | 85 | 5 | GO:0019902 | |
| GeneOntologyBiologicalProcess | epoxygenase P450 pathway | 2.50e-10 | 22 | 83 | 6 | GO:0019373 | |
| GeneOntologyBiologicalProcess | arachidonate metabolic process | 1.05e-08 | 68 | 83 | 7 | GO:0019369 | |
| GeneOntologyBiologicalProcess | xenobiotic metabolic process | 1.00e-07 | 141 | 83 | 8 | GO:0006805 | |
| GeneOntologyBiologicalProcess | omega-hydroxylase P450 pathway | 2.37e-07 | 14 | 83 | 4 | GO:0097267 | |
| GeneOntologyBiologicalProcess | long-chain fatty acid metabolic process | 6.80e-07 | 124 | 83 | 7 | GO:0001676 | |
| GeneOntologyBiologicalProcess | unsaturated fatty acid metabolic process | 8.44e-07 | 128 | 83 | 7 | GO:0033559 | |
| GeneOntologyBiologicalProcess | icosanoid metabolic process | 1.70e-06 | 142 | 83 | 7 | GO:0006690 | |
| GeneOntologyBiologicalProcess | cellular response to xenobiotic stimulus | 3.13e-06 | 222 | 83 | 8 | GO:0071466 | |
| GeneOntologyBiologicalProcess | phenylpropanoid metabolic process | 7.39e-06 | 10 | 83 | 3 | GO:0009698 | |
| GeneOntologyBiologicalProcess | coumarin metabolic process | 7.39e-06 | 10 | 83 | 3 | GO:0009804 | |
| GeneOntologyBiologicalProcess | olefinic compound metabolic process | 8.15e-06 | 180 | 83 | 7 | GO:0120254 | |
| GeneOntologyBiologicalProcess | xenobiotic catabolic process | 1.45e-05 | 37 | 83 | 4 | GO:0042178 | |
| GeneOntologyBiologicalProcess | monocarboxylic acid metabolic process | CYP2A6 CYP2A7 CYP2A13 CYP2C19 CYP2C8 CYP2C9 UGT1A6 CYP27A1 PRKAG1 CYP2U1 AKT2 MCCC1 | 3.46e-05 | 731 | 83 | 12 | GO:0032787 |
| GeneOntologyBiologicalProcess | fatty acid metabolic process | CYP2A6 CYP2A7 CYP2A13 CYP2C19 CYP2C8 CYP2C9 PRKAG1 CYP2U1 AKT2 | 9.79e-05 | 461 | 83 | 9 | GO:0006631 |
| GeneOntologyBiologicalProcess | monoterpenoid metabolic process | 2.37e-04 | 6 | 83 | 2 | GO:0016098 | |
| GeneOntologyBiologicalProcess | carboxylic acid metabolic process | BLMH CYP2A6 CYP2A7 CYP2A13 CYP2C19 CYP2C8 CYP2C9 UGT1A6 CYP27A1 PRKAG1 CYP2U1 AKT2 MCCC1 | 2.39e-04 | 1035 | 83 | 13 | GO:0019752 |
| GeneOntologyBiologicalProcess | response to xenobiotic stimulus | BLMH CYP2A6 CYP2A7 CYP2A13 CYP2C19 CYP2C8 CYP2C9 UGT1A6 CYP2U1 | 2.59e-04 | 525 | 83 | 9 | GO:0009410 |
| GeneOntologyBiologicalProcess | oxoacid metabolic process | BLMH CYP2A6 CYP2A7 CYP2A13 CYP2C19 CYP2C8 CYP2C9 UGT1A6 CYP27A1 PRKAG1 CYP2U1 AKT2 MCCC1 | 2.96e-04 | 1058 | 83 | 13 | GO:0043436 |
| GeneOntologyBiologicalProcess | organic acid metabolic process | BLMH CYP2A6 CYP2A7 CYP2A13 CYP2C19 CYP2C8 CYP2C9 UGT1A6 CYP27A1 PRKAG1 CYP2U1 AKT2 MCCC1 | 3.12e-04 | 1064 | 83 | 13 | GO:0006082 |
| GeneOntologyBiologicalProcess | mitotic sister chromatid cohesion | 4.08e-04 | 36 | 83 | 3 | GO:0007064 | |
| GeneOntologyBiologicalProcess | positive regulation of apoptotic cell clearance | 4.41e-04 | 8 | 83 | 2 | GO:2000427 | |
| GeneOntologyCellularComponent | microtubule | CYP2A6 CYP2A7 CYP2A13 DCDC2 KIF23 DNAH17 EML6 SPAG17 KIF17 RCC2 IQGAP1 | 1.30e-05 | 533 | 87 | 11 | GO:0005874 |
| GeneOntologyCellularComponent | axoneme | 2.52e-05 | 207 | 87 | 7 | GO:0005930 | |
| GeneOntologyCellularComponent | ciliary plasm | 2.60e-05 | 208 | 87 | 7 | GO:0097014 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | CYP2A6 CYP2A7 MYO3A CYP2A13 DCDC2 KIF23 DNAH17 EML6 EVPL SPAG17 KIF17 RCC2 IQGAP1 | 8.47e-05 | 899 | 87 | 13 | GO:0099513 |
| GeneOntologyCellularComponent | plasma membrane bounded cell projection cytoplasm | 3.57e-04 | 317 | 87 | 7 | GO:0032838 | |
| GeneOntologyCellularComponent | symbiont cell surface | 4.72e-04 | 8 | 87 | 2 | GO:0106139 | |
| GeneOntologyCellularComponent | sarcoplasmic reticulum | 5.00e-04 | 88 | 87 | 4 | GO:0016529 | |
| GeneOntologyCellularComponent | other organism part | 6.05e-04 | 9 | 87 | 2 | GO:0044217 | |
| GeneOntologyCellularComponent | platelet dense tubular network membrane | 6.05e-04 | 9 | 87 | 2 | GO:0031095 | |
| GeneOntologyCellularComponent | cytoplasmic region | 7.61e-04 | 360 | 87 | 7 | GO:0099568 | |
| GeneOntologyCellularComponent | platelet dense tubular network | 9.19e-04 | 11 | 87 | 2 | GO:0031094 | |
| GeneOntologyCellularComponent | chromosome, centromeric region | 1.04e-03 | 276 | 87 | 6 | GO:0000775 | |
| GeneOntologyCellularComponent | supramolecular fiber | CYP2A6 CYP2A7 MYO3A CYP2A13 DCDC2 KIF23 DNAH17 EML6 EVPL SPAG17 KIF17 RCC2 IQGAP1 | 1.14e-03 | 1179 | 87 | 13 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | CYP2A6 CYP2A7 MYO3A CYP2A13 DCDC2 KIF23 DNAH17 EML6 EVPL SPAG17 KIF17 RCC2 IQGAP1 | 1.21e-03 | 1187 | 87 | 13 | GO:0099081 |
| GeneOntologyCellularComponent | sarcoplasm | 1.32e-03 | 114 | 87 | 4 | GO:0016528 | |
| MousePheno | decreased intestinal cholesterol absorption | 1.23e-06 | 17 | 69 | 4 | MP:0002647 | |
| MousePheno | abnormal intestinal cholesterol absorption | 1.99e-06 | 19 | 69 | 4 | MP:0002645 | |
| MousePheno | abnormal intestinal lipid absorption | 1.55e-05 | 31 | 69 | 4 | MP:0005342 | |
| MousePheno | abnormal bile salt homeostasis | 8.26e-05 | 47 | 69 | 4 | MP:0005365 | |
| MousePheno | carpoptosis | 1.43e-04 | 4 | 69 | 2 | MP:0005162 | |
| MousePheno | abnormal intestinal absorption | 2.02e-04 | 59 | 69 | 4 | MP:0001666 | |
| Domain | Cyt_P450_E_grp-I | 2.47e-11 | 45 | 85 | 8 | IPR002401 | |
| Domain | Cyt_P450_CS | 9.86e-11 | 53 | 85 | 8 | IPR017972 | |
| Domain | CYTOCHROME_P450 | 1.81e-10 | 57 | 85 | 8 | PS00086 | |
| Domain | - | 2.09e-10 | 58 | 85 | 8 | 1.10.630.10 | |
| Domain | p450 | 2.09e-10 | 58 | 85 | 8 | PF00067 | |
| Domain | Cyt_P450 | 2.77e-10 | 60 | 85 | 8 | IPR001128 | |
| Domain | Cyt_P450_E_grp-I_CYP2A-like | 3.63e-07 | 4 | 85 | 3 | IPR008067 | |
| Domain | Cadherin_tail | 6.74e-07 | 37 | 85 | 5 | PF15974 | |
| Domain | Cadherin_CBD | 6.74e-07 | 37 | 85 | 5 | IPR031904 | |
| Domain | Cadherin_2 | 1.16e-05 | 65 | 85 | 5 | PF08266 | |
| Domain | Cadherin_N | 1.16e-05 | 65 | 85 | 5 | IPR013164 | |
| Domain | Cadherin | 1.63e-05 | 118 | 85 | 6 | IPR002126 | |
| Domain | InsP3_rcpt-bd | 6.12e-05 | 3 | 85 | 2 | IPR000493 | |
| Domain | Cadherin_CS | 1.40e-04 | 109 | 85 | 5 | IPR020894 | |
| Domain | CADHERIN_1 | 1.66e-04 | 113 | 85 | 5 | PS00232 | |
| Domain | Cadherin | 1.66e-04 | 113 | 85 | 5 | PF00028 | |
| Domain | CADHERIN_2 | 1.72e-04 | 114 | 85 | 5 | PS50268 | |
| Domain | - | 1.72e-04 | 114 | 85 | 5 | 2.60.40.60 | |
| Domain | CA | 1.80e-04 | 115 | 85 | 5 | SM00112 | |
| Domain | Cadherin-like | 1.87e-04 | 116 | 85 | 5 | IPR015919 | |
| Domain | Anaphylatoxin_comp_syst | 2.03e-04 | 5 | 85 | 2 | IPR018081 | |
| Domain | Anaphylatoxn_comp_syst_dom | 2.03e-04 | 5 | 85 | 2 | IPR001840 | |
| Domain | RIH_assoc | 3.03e-04 | 6 | 85 | 2 | PF08454 | |
| Domain | RIH_assoc-dom | 3.03e-04 | 6 | 85 | 2 | IPR013662 | |
| Domain | RIH_dom | 3.03e-04 | 6 | 85 | 2 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 3.03e-04 | 6 | 85 | 2 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 3.03e-04 | 6 | 85 | 2 | IPR015925 | |
| Domain | - | 3.03e-04 | 6 | 85 | 2 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 3.03e-04 | 6 | 85 | 2 | PF01365 | |
| Domain | Ins145_P3_rec | 3.03e-04 | 6 | 85 | 2 | PF08709 | |
| Domain | Spectrin/alpha-actinin | 4.10e-04 | 32 | 85 | 3 | IPR018159 | |
| Domain | SPEC | 4.10e-04 | 32 | 85 | 3 | SM00150 | |
| Domain | ANATO | 4.24e-04 | 7 | 85 | 2 | SM00104 | |
| Domain | ANATO | 4.24e-04 | 7 | 85 | 2 | PF01821 | |
| Domain | ANAPHYLATOXIN_2 | 4.24e-04 | 7 | 85 | 2 | PS01178 | |
| Domain | ANAPHYLATOXIN_1 | 4.24e-04 | 7 | 85 | 2 | PS01177 | |
| Domain | Anaphylatoxin/fibulin | 4.24e-04 | 7 | 85 | 2 | IPR000020 | |
| Domain | Thiol-ester_cl | 5.63e-04 | 8 | 85 | 2 | PF10569 | |
| Domain | MacrogloblnA2_thiol-ester-bond | 5.63e-04 | 8 | 85 | 2 | IPR019565 | |
| Domain | MacrogloblnA2_CS | 5.63e-04 | 8 | 85 | 2 | IPR019742 | |
| Domain | A2M_N | 9.00e-04 | 10 | 85 | 2 | PF01835 | |
| Domain | MIR | 9.00e-04 | 10 | 85 | 2 | PS50919 | |
| Domain | MIR | 9.00e-04 | 10 | 85 | 2 | PF02815 | |
| Domain | MIR | 9.00e-04 | 10 | 85 | 2 | SM00472 | |
| Domain | A2M_N | 9.00e-04 | 10 | 85 | 2 | IPR002890 | |
| Domain | A-macroglobulin_rcpt-bd | 9.00e-04 | 10 | 85 | 2 | IPR009048 | |
| Domain | ALPHA_2_MACROGLOBULIN | 9.00e-04 | 10 | 85 | 2 | PS00477 | |
| Domain | A2M | 9.00e-04 | 10 | 85 | 2 | PF00207 | |
| Domain | MIR_motif | 9.00e-04 | 10 | 85 | 2 | IPR016093 | |
| Domain | A2M_N_2 | 9.00e-04 | 10 | 85 | 2 | IPR011625 | |
| Domain | A2M_comp | 9.00e-04 | 10 | 85 | 2 | IPR011626 | |
| Domain | A2M_N_2 | 9.00e-04 | 10 | 85 | 2 | PF07703 | |
| Domain | A2M_recep | 9.00e-04 | 10 | 85 | 2 | PF07677 | |
| Domain | A2M_comp | 9.00e-04 | 10 | 85 | 2 | PF07678 | |
| Domain | Macroglobln_a2 | 9.00e-04 | 10 | 85 | 2 | IPR001599 | |
| Domain | P-loop_NTPase | MYO3A KIF23 SAMD9L TJP1 MAGI3 ZNFX1 CHST1 SMC5 KIF17 ABCA9 IQGAP1 | 1.57e-03 | 848 | 85 | 11 | IPR027417 |
| Domain | Ion_trans_dom | 1.82e-03 | 114 | 85 | 4 | IPR005821 | |
| Domain | Ion_trans | 1.82e-03 | 114 | 85 | 4 | PF00520 | |
| Domain | C345C | 2.66e-03 | 17 | 85 | 2 | SM00643 | |
| Domain | Terpenoid_cyclase/PrenylTrfase | 2.99e-03 | 18 | 85 | 2 | IPR008930 | |
| Domain | NTR | 3.33e-03 | 19 | 85 | 2 | PF01759 | |
| Domain | Netrin_module_non-TIMP | 3.33e-03 | 19 | 85 | 2 | IPR018933 | |
| Domain | HEAT_REPEAT | 4.00e-03 | 70 | 85 | 3 | PS50077 | |
| Domain | ARM-type_fold | 4.50e-03 | 339 | 85 | 6 | IPR016024 | |
| Pathway | REACTOME_CYP2E1_REACTIONS | 3.44e-12 | 11 | 65 | 6 | M27130 | |
| Pathway | WP_OXIDATION_BY_CYTOCHROME_P450 | 3.64e-10 | 62 | 65 | 8 | M39653 | |
| Pathway | REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE | 4.73e-10 | 64 | 65 | 8 | M5650 | |
| Pathway | REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE | 6.09e-10 | 66 | 65 | 8 | MM14839 | |
| Pathway | REACTOME_XENOBIOTICS | 7.20e-10 | 23 | 65 | 6 | M5372 | |
| Pathway | REACTOME_XENOBIOTICS | 1.25e-09 | 25 | 65 | 6 | MM14846 | |
| Pathway | REACTOME_CYP2E1_REACTIONS | 1.38e-09 | 12 | 65 | 5 | MM14847 | |
| Pathway | WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II | CYP2A6 CYP2A7 CYP2A13 CYP2C19 CYP2C8 CYP2C9 UGT1A6 CYP27A1 CYP2U1 CHST1 | 1.03e-08 | 183 | 65 | 10 | M39588 |
| Pathway | KEGG_RETINOL_METABOLISM | 1.61e-08 | 64 | 65 | 7 | M9488 | |
| Pathway | REACTOME_PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS | 2.38e-08 | 104 | 65 | 8 | M738 | |
| Pathway | REACTOME_PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS | 2.57e-08 | 105 | 65 | 8 | MM14842 | |
| Pathway | KEGG_DRUG_METABOLISM_CYTOCHROME_P450 | 3.70e-08 | 72 | 65 | 7 | M9257 | |
| Pathway | REACTOME_SYNTHESIS_OF_16_20_HYDROXYEICOSATETRAENOIC_ACIDS_HETE | 5.10e-08 | 9 | 65 | 4 | M27143 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | CYP2A6 CYP2A7 CYP2A13 CYP2C19 CYP2C8 CYP2C9 UGT1A6 CYP27A1 CYP2U1 | 6.98e-07 | 220 | 65 | 9 | M10320 |
| Pathway | WP_TAMOXIFEN_METABOLISM | 2.32e-06 | 21 | 65 | 4 | M39631 | |
| Pathway | REACTOME_SYNTHESIS_OF_EPOXY_EET_AND_DIHYDROXYEICOSATRIENOIC_ACIDS_DHET | 5.15e-06 | 8 | 65 | 3 | M27135 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | 7.04e-06 | 219 | 65 | 8 | MM14838 | |
| Pathway | WP_CONSTITUTIVE_ANDROSTANE_RECEPTOR_PATHWAY | 1.18e-05 | 31 | 65 | 4 | M39476 | |
| Pathway | WP_PREGNANE_X_RECEPTOR_PATHWAY | 1.34e-05 | 32 | 65 | 4 | M39567 | |
| Pathway | REACTOME_SYNTHESIS_OF_16_20_HYDROXYEICOSATETRAENOIC_ACIDS_HETE | 1.50e-05 | 11 | 65 | 3 | MM14863 | |
| Pathway | WP_OCTADECANOID_FORMATION_FROM_LINOLEIC_ACID | 2.00e-05 | 12 | 65 | 3 | M48064 | |
| Pathway | REACTOME_MITOTIC_TELOPHASE_CYTOKINESIS | 2.59e-05 | 13 | 65 | 3 | MM15363 | |
| Pathway | REACTOME_MITOTIC_TELOPHASE_CYTOKINESIS | 2.59e-05 | 13 | 65 | 3 | M27661 | |
| Pathway | REACTOME_ASPIRIN_ADME | 4.87e-05 | 44 | 65 | 4 | M45014 | |
| Pathway | REACTOME_FATTY_ACIDS | 7.27e-05 | 18 | 65 | 3 | MM14841 | |
| Pathway | KEGG_DRUG_METABOLISM_OTHER_ENZYMES | 8.74e-05 | 51 | 65 | 4 | M17726 | |
| Pathway | KEGG_ARACHIDONIC_ACID_METABOLISM | 1.45e-04 | 58 | 65 | 4 | M5410 | |
| Pathway | REACTOME_ARACHIDONIC_ACID_METABOLISM | 1.55e-04 | 59 | 65 | 4 | M27140 | |
| Pathway | WP_ESTROGEN_METABOLISM_WP5276 | 1.77e-04 | 24 | 65 | 3 | M46445 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_NNK_TO_DNA_ADDUCTS | 2.07e-04 | 5 | 65 | 2 | M47808 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PRKN_TO_MGLUR1_SIGNALING_PATHWAY | 2.07e-04 | 5 | 65 | 2 | M49000 | |
| Pathway | KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450 | 3.00e-04 | 70 | 65 | 4 | M16794 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_PLCD_ITPR_SIGNALING_PATHWAY | 3.10e-04 | 6 | 65 | 2 | M47960 | |
| Pathway | REACTOME_BIOSYNTHESIS_OF_MARESIN_LIKE_SPMS | 3.10e-04 | 6 | 65 | 2 | M27909 | |
| Pathway | KEGG_LINOLEIC_ACID_METABOLISM | 3.14e-04 | 29 | 65 | 3 | M2920 | |
| Pathway | WP_ARACHIDONATE_EPOXYGENASE_EPOXIDE_HYDROLASE | 4.33e-04 | 7 | 65 | 2 | M39515 | |
| Pathway | REACTOME_ACTIVATION_OF_C3_AND_C5 | 4.33e-04 | 7 | 65 | 2 | MM14685 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ESTABLISHMENT_OF_COHESION | 4.33e-04 | 7 | 65 | 2 | M47869 | |
| Pathway | REACTOME_SYNTHESIS_OF_EPOXY_EET_AND_DIHYDROXYEICOSATRIENOIC_ACIDS_DHET | 4.33e-04 | 7 | 65 | 2 | MM14856 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_SECRETION | 4.55e-04 | 78 | 65 | 4 | M1921 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CLASSICAL_PATHWAY_OF_COMPLEMENT_CASCADE_C4_C2_TO_C3_CONVERTASE_FORMATION | 5.76e-04 | 8 | 65 | 2 | M47872 | |
| Pathway | REACTOME_BIOSYNTHESIS_OF_MARESINS | 5.76e-04 | 8 | 65 | 2 | M27891 | |
| Pathway | REACTOME_ACTIVATION_OF_C3_AND_C5 | 5.76e-04 | 8 | 65 | 2 | M27031 | |
| Pathway | SIG_PIP3_SIGNALING_IN_B_LYMPHOCYTES | 5.99e-04 | 36 | 65 | 3 | M1315 | |
| Pathway | WP_VITAMIN_DSENSITIVE_CALCIUM_SIGNALING_IN_DEPRESSION | 5.99e-04 | 36 | 65 | 3 | M39831 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BCR_PLCG_ITPR_SIGNALING_PATHWAY | 7.38e-04 | 9 | 65 | 2 | M47852 | |
| Pathway | REACTOME_COHESIN_LOADING_ONTO_CHROMATIN | 9.20e-04 | 10 | 65 | 2 | M27178 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SPTBN2_TO_MGLUR1_TRPC3_SIGNALING_PATHWAY | 9.20e-04 | 10 | 65 | 2 | M47661 | |
| Pathway | REACTOME_COHESIN_LOADING_ONTO_CHROMATIN | 9.20e-04 | 10 | 65 | 2 | MM14892 | |
| Pathway | REACTOME_GLUCAGON_LIKE_PEPTIDE_1_GLP1_REGULATES_INSULIN_SECRETION | 9.45e-04 | 42 | 65 | 3 | M791 | |
| Pathway | KEGG_MEDICUS_REFERENCE_LECTIN_PATHWAY_OF_COMPLEMENT_CASCADE_C4_C2_TO_C3_CONVERTASE_FORMATION | 1.12e-03 | 11 | 65 | 2 | M47874 | |
| Pathway | REACTOME_ESTABLISHMENT_OF_SISTER_CHROMATID_COHESION | 1.12e-03 | 11 | 65 | 2 | M27177 | |
| Pathway | REACTOME_ESTABLISHMENT_OF_SISTER_CHROMATID_COHESION | 1.12e-03 | 11 | 65 | 2 | MM14891 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_PRKCG_TO_MGLUR1_TRPC3_SIGNALING_PATHWAY | 1.12e-03 | 11 | 65 | 2 | M49033 | |
| Pathway | BIOCARTA_LECTIN_PATHWAY | 1.12e-03 | 11 | 65 | 2 | MM1430 | |
| Pathway | REACTOME_CLEC7A_DECTIN_1_INDUCES_NFAT_ACTIVATION | 1.12e-03 | 11 | 65 | 2 | M27466 | |
| Pathway | SIG_CHEMOTAXIS | 1.16e-03 | 45 | 65 | 3 | M5193 | |
| Pathway | SIG_BCR_SIGNALING_PATHWAY | 1.23e-03 | 46 | 65 | 3 | M8626 | |
| Pathway | WP_VALPROIC_ACID_PATHWAY | 1.34e-03 | 12 | 65 | 2 | M39371 | |
| Pathway | BIOCARTA_CLASSIC_PATHWAY | 1.34e-03 | 12 | 65 | 2 | MM1368 | |
| Pathway | REACTOME_BIOSYNTHESIS_OF_MARESINS | 1.34e-03 | 12 | 65 | 2 | MM15616 | |
| Pathway | REACTOME_INTEGRATION_OF_ENERGY_METABOLISM | 1.54e-03 | 108 | 65 | 4 | M17034 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MGLUR1_TRPC3_SIGNALING_PATHWAY | 1.58e-03 | 13 | 65 | 2 | M47656 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PSEN1_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 1.58e-03 | 13 | 65 | 2 | M47696 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_SIGMAR1_TO_CA2_APOPTOTIC_PATHWAY | 1.58e-03 | 13 | 65 | 2 | M47751 | |
| Pathway | BIOCARTA_LECTIN_PATHWAY | 1.58e-03 | 13 | 65 | 2 | M4732 | |
| Pathway | REACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS | 1.58e-03 | 13 | 65 | 2 | MM14553 | |
| Pathway | REACTOME_DRUG_ADME | 1.59e-03 | 109 | 65 | 4 | M45012 | |
| Pathway | WP_CODEINE_AND_MORPHINE_METABOLISM | 1.84e-03 | 14 | 65 | 2 | M39328 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES | 1.84e-03 | 14 | 65 | 2 | MM15842 | |
| Pathway | REACTOME_FATTY_ACIDS | 2.11e-03 | 15 | 65 | 2 | M27126 | |
| Pathway | BIOCARTA_CLASSIC_PATHWAY | 2.11e-03 | 15 | 65 | 2 | M7146 | |
| Pathway | REACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS | 2.41e-03 | 16 | 65 | 2 | M26945 | |
| Pathway | WP_DEREGULATION_OF_RAB_AND_RAB_EFFECTOR_GENES_IN_BLADDER_CANCER | 2.41e-03 | 16 | 65 | 2 | M39391 | |
| Pathway | WP_COMPLEMENT_ACTIVATION_CLASSICAL_PATHWAY | 2.72e-03 | 17 | 65 | 2 | MM15944 | |
| Pathway | BIOCARTA_COMP_PATHWAY | 2.72e-03 | 17 | 65 | 2 | MM1369 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_SECRETION | 2.78e-03 | 61 | 65 | 3 | MM15071 | |
| Pathway | REACTOME_ARACHIDONIC_ACID_METABOLISM | 2.78e-03 | 61 | 65 | 3 | MM14861 | |
| Pathway | WP_MFAP5_EFFECT_ON_PERMEABILITY_AND_MOTILITY_OF_ENDOTHELIAL_CELLS_VIA_CYTOSKELETON_REARRANGEMENT | 3.05e-03 | 18 | 65 | 2 | M39808 | |
| Pathway | REACTOME_VEGFR2_MEDIATED_CELL_PROLIFERATION | 3.40e-03 | 19 | 65 | 2 | M27423 | |
| Pathway | REACTOME_BIOSYNTHESIS_OF_SPECIALIZED_PRORESOLVING_MEDIATORS_SPMS | 3.40e-03 | 19 | 65 | 2 | M27889 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 3.40e-03 | 19 | 65 | 2 | M47760 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TCR_PLCG_ITPR_SIGNALING_PATHWAY | 3.40e-03 | 19 | 65 | 2 | M47733 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MACHR_CA2_APOPTOTIC_PATHWAY | 3.77e-03 | 20 | 65 | 2 | M47688 | |
| Pathway | BIOCARTA_COMP_PATHWAY | 3.77e-03 | 20 | 65 | 2 | M917 | |
| Pubmed | Molecular genetics of the human cytochrome P450 monooxygenase superfamily. | 8.31e-12 | 20 | 88 | 6 | 9890157 | |
| Pubmed | 1.01e-11 | 70 | 88 | 8 | 15128046 | ||
| Pubmed | 1.16e-11 | 9 | 88 | 5 | 37838304 | ||
| Pubmed | Novel DNA sequence variations of cytochrome P450 genes in the Han Chinese population. | 1.82e-10 | 14 | 88 | 5 | 19290787 | |
| Pubmed | 2.72e-10 | 15 | 88 | 5 | 15640798 | ||
| Pubmed | 5.58e-10 | 17 | 88 | 5 | 29911975 | ||
| Pubmed | 5.58e-10 | 17 | 88 | 5 | 27197076 | ||
| Pubmed | CNR/Pcdhalpha family in subplate neurons, and developing cortical connectivity. | 7.72e-10 | 18 | 88 | 5 | 15570159 | |
| Pubmed | Genomic organization of the family of CNR cadherin genes in mice and humans. | 7.72e-10 | 18 | 88 | 5 | 10662547 | |
| Pubmed | Comparative expression profiling of 40 mouse cytochrome P450 genes in embryonic and adult tissues. | 1.44e-09 | 44 | 88 | 6 | 12745259 | |
| Pubmed | 3.78e-09 | 24 | 88 | 5 | 24698270 | ||
| Pubmed | 7.94e-09 | 10 | 88 | 4 | 19651758 | ||
| Pubmed | Interaction with protocadherin-gamma regulates the cell surface expression of protocadherin-alpha. | 8.68e-09 | 28 | 88 | 5 | 15347688 | |
| Pubmed | Elucidation of the BMI1 interactome identifies novel regulatory roles in glioblastoma. | 1.18e-08 | 329 | 88 | 10 | 34316702 | |
| Pubmed | 1.25e-08 | 11 | 88 | 4 | 15039299 | ||
| Pubmed | Genetic variation in eleven phase I drug metabolism genes in an ethnically diverse population. | 1.25e-08 | 11 | 88 | 4 | 15469410 | |
| Pubmed | 1.57e-08 | 3 | 88 | 3 | 28687336 | ||
| Pubmed | Regulation of bile acid metabolism in mouse models with hydrophobic bile acid composition. | 1.57e-08 | 3 | 88 | 3 | 31645370 | |
| Pubmed | 1.57e-08 | 3 | 88 | 3 | 3346244 | ||
| Pubmed | A 2.4-megabase physical map spanning the CYP2C gene cluster on chromosome 10q24. | 1.57e-08 | 3 | 88 | 3 | 8530044 | |
| Pubmed | 1.57e-08 | 3 | 88 | 3 | 2733794 | ||
| Pubmed | 1.57e-08 | 3 | 88 | 3 | 21173785 | ||
| Pubmed | 1.57e-08 | 3 | 88 | 3 | 8297477 | ||
| Pubmed | 1.57e-08 | 3 | 88 | 3 | 8188299 | ||
| Pubmed | 1.57e-08 | 3 | 88 | 3 | 8484736 | ||
| Pubmed | 1.57e-08 | 3 | 88 | 3 | 8250953 | ||
| Pubmed | 1.57e-08 | 3 | 88 | 3 | 35134542 | ||
| Pubmed | 1.57e-08 | 3 | 88 | 3 | 24430292 | ||
| Pubmed | 1.57e-08 | 3 | 88 | 3 | 2703500 | ||
| Pubmed | Distribution of CYP2C polymorphisms in an Amerindian population of Brazil. | 1.57e-08 | 3 | 88 | 3 | 21977947 | |
| Pubmed | 1.57e-08 | 3 | 88 | 3 | 1417950 | ||
| Pubmed | 1.57e-08 | 3 | 88 | 3 | 24045421 | ||
| Pubmed | 1.57e-08 | 3 | 88 | 3 | 20665013 | ||
| Pubmed | 1.57e-08 | 3 | 88 | 3 | 32987105 | ||
| Pubmed | 1.57e-08 | 3 | 88 | 3 | 27803446 | ||
| Pubmed | 1.57e-08 | 3 | 88 | 3 | 22217847 | ||
| Pubmed | 1.57e-08 | 3 | 88 | 3 | 2765478 | ||
| Pubmed | 1.57e-08 | 3 | 88 | 3 | 2415518 | ||
| Pubmed | Differential distribution of CYP2A6 and CYP2A13 in the human respiratory tract. | 1.57e-08 | 3 | 88 | 3 | 22890016 | |
| Pubmed | Characterisation of CYP2C8, CYP2C9 and CYP2C19 polymorphisms in a Ghanaian population. | 1.57e-08 | 3 | 88 | 3 | 19954515 | |
| Pubmed | 1.57e-08 | 3 | 88 | 3 | 23118231 | ||
| Pubmed | The DNA sequence and comparative analysis of human chromosome 5. | 3.86e-08 | 75 | 88 | 6 | 15372022 | |
| Pubmed | 5.11e-08 | 15 | 88 | 4 | 29968852 | ||
| Pubmed | 6.25e-08 | 4 | 88 | 3 | 2009263 | ||
| Pubmed | Allele frequency differences of cytochrome P450 polymorphisms in a sample of New Zealand Māori. | 6.25e-08 | 4 | 88 | 3 | 18425152 | |
| Pubmed | 6.25e-08 | 4 | 88 | 3 | 9408084 | ||
| Pubmed | 6.25e-08 | 4 | 88 | 3 | 10490589 | ||
| Pubmed | 6.25e-08 | 4 | 88 | 3 | 21798861 | ||
| Pubmed | Two steroid 15 alpha-hydroxylase genes and a homologous gene family in mice. | 6.25e-08 | 4 | 88 | 3 | 1970547 | |
| Pubmed | Polymorphism of CYP2D6, CYP2C19, CYP2C9 and CYP2C8 in the Faroese population. | 6.25e-08 | 4 | 88 | 3 | 16025294 | |
| Pubmed | Biochemistry and molecular biology of the human CYP2C subfamily. | 6.25e-08 | 4 | 88 | 3 | 7704034 | |
| Pubmed | 6.25e-08 | 4 | 88 | 3 | 36718958 | ||
| Pubmed | 6.25e-08 | 4 | 88 | 3 | 7565685 | ||
| Pubmed | 6.25e-08 | 4 | 88 | 3 | 28990182 | ||
| Pubmed | 6.25e-08 | 4 | 88 | 3 | 23755828 | ||
| Pubmed | 6.25e-08 | 4 | 88 | 3 | 19706858 | ||
| Pubmed | PDS5B KIF23 TJP1 PRRC2C DOCK7 SMARCC2 PDS5A EIF4G3 MVP CNOT1 RCC2 IQGAP1 | 9.72e-08 | 653 | 88 | 12 | 22586326 | |
| Pubmed | PDS5B CACNA1E CYP2A6 CYP2A13 TJP1 PRRC2C EML6 ZSCAN26 DKC1 SMARCC2 MAGI3 MAPK6 EIF4G3 SPAG17 YY1 CHRNA1 IQGAP1 | 1.08e-07 | 1442 | 88 | 17 | 35575683 | |
| Pubmed | Prevalence of CYP450 gene variations in patients with type 2 diabetes. | 1.56e-07 | 5 | 88 | 3 | 20857895 | |
| Pubmed | 1.56e-07 | 5 | 88 | 3 | 19415824 | ||
| Pubmed | 1.56e-07 | 5 | 88 | 3 | 16141797 | ||
| Pubmed | 1.56e-07 | 5 | 88 | 3 | 19029318 | ||
| Pubmed | 3.11e-07 | 6 | 88 | 3 | 7668294 | ||
| Pubmed | 3.11e-07 | 6 | 88 | 3 | 8587134 | ||
| Pubmed | Genetic polymorphism of cytochrome P450s and P-glycoprotein in the Finnish population. | 3.11e-07 | 6 | 88 | 3 | 17635176 | |
| Pubmed | Clustered gamma-protocadherins regulate cortical interneuron programmed cell death. | 3.49e-07 | 57 | 88 | 5 | 32633719 | |
| Pubmed | CTCF Governs the Identity and Migration of MGE-Derived Cortical Interneurons. | 3.81e-07 | 58 | 88 | 5 | 30377227 | |
| Pubmed | 5.44e-07 | 7 | 88 | 3 | 14630516 | ||
| Pubmed | 5.44e-07 | 7 | 88 | 3 | 9630227 | ||
| Pubmed | 6.31e-07 | 193 | 88 | 7 | 19343046 | ||
| Pubmed | 6.42e-07 | 27 | 88 | 4 | 20173083 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | PDS5B ZNF131 LIG3 KIF23 TJP1 PRRC2C DKC1 SMARCC2 PDS5A MCCC1 SMC5 YY1 RCC2 | 8.25e-07 | 954 | 88 | 13 | 36373674 |
| Pubmed | Comparative DNA sequence analysis of mouse and human protocadherin gene clusters. | 8.50e-07 | 68 | 88 | 5 | 11230163 | |
| Pubmed | 8.69e-07 | 8 | 88 | 3 | 18356043 | ||
| Pubmed | A striking organization of a large family of human neural cadherin-like cell adhesion genes. | 1.13e-06 | 72 | 88 | 5 | 10380929 | |
| Pubmed | Cadherin superfamily genes: functions, genomic organization, and neurologic diversity. | 1.30e-06 | 74 | 88 | 5 | 10817752 | |
| Pubmed | 1.58e-06 | 77 | 88 | 5 | 10835267 | ||
| Pubmed | Scc1 sumoylation by Mms21 promotes sister chromatid recombination through counteracting Wapl. | 1.85e-06 | 10 | 88 | 3 | 22751501 | |
| Pubmed | 1.85e-06 | 10 | 88 | 3 | 20602612 | ||
| Pubmed | Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes. | 1.91e-06 | 80 | 88 | 5 | 10716726 | |
| Pubmed | 1.96e-06 | 329 | 88 | 8 | 17474147 | ||
| Pubmed | Diversity revealed by a novel family of cadherins expressed in neurons at a synaptic complex. | 2.55e-06 | 11 | 88 | 3 | 9655502 | |
| Pubmed | 3.81e-06 | 360 | 88 | 8 | 33111431 | ||
| Pubmed | 4.48e-06 | 95 | 88 | 5 | 24029230 | ||
| Pubmed | 5.58e-06 | 14 | 88 | 3 | 20970553 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 22737222 | ||
| Pubmed | Deficiency of C4 from donor or recipient mouse fails to prevent renal allograft rejection. | 6.33e-06 | 2 | 88 | 2 | 16565498 | |
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 15998580 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 7574697 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 16305586 | ||
| Pubmed | Structural polymorphism of murine C4 and its linkage to H-2. | 6.33e-06 | 2 | 88 | 2 | 7373044 | |
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 19062096 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 16198656 | ||
| Pubmed | The chemical structure of the C4d fragment of the human complement component C4. | 6.33e-06 | 2 | 88 | 2 | 3696167 | |
| Pubmed | Restriction fragment length polymorphism of the murine C4 and Slp genes: two C4 groups. | 6.33e-06 | 2 | 88 | 2 | 1357031 | |
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 30562214 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 26122864 | ||
| Pubmed | Structural comparison of human C4A3 and C4B1 after proteolytic activation by C1s. | 6.33e-06 | 2 | 88 | 2 | 16098595 | |
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 12325023 | ||
| Pubmed | Activation of innate and humoral immunity in the peripheral nervous system of ALS transgenic mice. | 6.33e-06 | 2 | 88 | 2 | 19933335 | |
| Interaction | PCDHA10 interactions | 3.32e-08 | 22 | 87 | 5 | int:PCDHA10 | |
| Interaction | CYP2A7 interactions | 7.77e-08 | 3 | 87 | 3 | int:CYP2A7 | |
| Interaction | FMR1 interactions | KIF23 TJP1 PRRC2C DOCK7 DKC1 SMARCC2 MAGI3 ZNFX1 MVP CNOT1 USP33 IQGAP1 | 3.21e-06 | 536 | 87 | 12 | int:FMR1 |
| Interaction | LGR4 interactions | 1.77e-05 | 262 | 87 | 8 | int:LGR4 | |
| Interaction | PCDHA7 interactions | 2.73e-05 | 14 | 87 | 3 | int:PCDHA7 | |
| Interaction | PCDHA2 interactions | 2.73e-05 | 14 | 87 | 3 | int:PCDHA2 | |
| Cytoband | 5q31 | 3.00e-06 | 115 | 88 | 5 | 5q31 | |
| Cytoband | 15q21 | 1.98e-04 | 11 | 88 | 2 | 15q21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5q31 | 2.81e-04 | 298 | 88 | 5 | chr5q31 | |
| Cytoband | 10q24 | 2.07e-03 | 35 | 88 | 2 | 10q24 | |
| Cytoband | 1p36.12 | 2.57e-03 | 39 | 88 | 2 | 1p36.12 | |
| Cytoband | 19q13.2 | 3.93e-03 | 164 | 88 | 3 | 19q13.2 | |
| GeneFamily | Cytochrome P450 family 2 | 2.18e-11 | 35 | 61 | 7 | 1001 | |
| GeneFamily | Clustered protocadherins | 2.42e-06 | 64 | 61 | 5 | 20 | |
| GeneFamily | Inositol 1,4,5-triphosphate receptors|Protein phosphatase 1 regulatory subunits | 3.35e-05 | 3 | 61 | 2 | 297 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 3.97e-04 | 9 | 61 | 2 | 1234 | |
| GeneFamily | Calcium voltage-gated channel subunits|Membrane associated guanylate kinases | 3.45e-03 | 26 | 61 | 2 | 904 | |
| GeneFamily | Complement system|Sushi domain containing | 6.55e-03 | 36 | 61 | 2 | 492 | |
| GeneFamily | Glycosyltransferase family 6|Blood group antigens | 6.91e-03 | 37 | 61 | 2 | 454 | |
| GeneFamily | Kinesins|Pleckstrin homology domain containing | 1.05e-02 | 46 | 61 | 2 | 622 | |
| Coexpression | WENG_POR_DOSAGE | 4.79e-08 | 30 | 87 | 5 | MM1199 | |
| Coexpression | MITSIADES_RESPONSE_TO_APLIDIN_DN | 2.02e-05 | 250 | 87 | 7 | M11318 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.38e-09 | 191 | 88 | 8 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.38e-09 | 191 | 88 | 8 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Synpr-Inhibitory_Neuron.Gad1Gad2.Synpr-Nnat_(Neuron.Gad1Gad2.Synpr-Nnat)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 7.40e-07 | 85 | 88 | 5 | 642755ed2b562dd5e599a04a2b9730e8d29aefe8 | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Synpr-Inhibitory_Neuron.Gad1Gad2.Synpr-Nnat_(Neuron.Gad1Gad2.Synpr-Nnat)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 7.40e-07 | 85 | 88 | 5 | 2429bacccd103e5b2414264b4aff3103ed9d7cec | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.20e-06 | 191 | 88 | 6 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.33e-06 | 193 | 88 | 6 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-Lgr5+_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.09e-05 | 168 | 88 | 5 | d69452e2cfeb74023b5cf3d09064d7dcad0008ec | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-basal_proximal|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.75e-05 | 178 | 88 | 5 | 9534c4f4e950bb1498c1737ca1713e7f37d0aff2 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.06e-05 | 182 | 88 | 5 | f8c73baaaca145e2efc48f10f636feb79c8fc779 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 3.22e-05 | 184 | 88 | 5 | 67164bb6bcae7322cb89b585c7aa10bce35b0ecd | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.22e-05 | 184 | 88 | 5 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.31e-05 | 185 | 88 | 5 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 3.95e-05 | 192 | 88 | 5 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| Computational | Genes in the cancer module 135. | 4.49e-06 | 25 | 49 | 4 | MODULE_135 | |
| Computational | Cytochrome P450. | 3.13e-05 | 14 | 49 | 3 | MODULE_106 | |
| Computational | Neighborhood of CYP2B6 | 6.94e-05 | 49 | 49 | 4 | GNF2_CYP2B6 | |
| Computational | Neighborhood of CEBPA | 1.98e-04 | 64 | 49 | 4 | GNF2_CEBPA | |
| Computational | Neighborhood of IGF1 | 2.15e-04 | 26 | 49 | 3 | GNF2_IGF1 | |
| Drug | diosmetin | BLMH CYP2A6 CYP2A7 CYP2A13 CYP2C19 CYP2C8 CYP2C9 UGT1A6 CYP27A1 CYP2U1 | 1.09e-12 | 85 | 88 | 10 | CID005281612 |
| Drug | aminoglutethimide | CYP2A6 CYP2A7 CYP2A13 CYP2C19 CYP2C8 CYP2C9 AGL CYP27A1 CYP2U1 SNURF | 1.35e-10 | 137 | 88 | 10 | CID000002145 |
| Drug | AC1L1KIN | CYP2A6 CYP2A7 CYP2A13 CYP2C19 CYP2C8 CYP2C9 CYP27A1 CYP2U1 MAPK6 | 1.81e-10 | 100 | 88 | 9 | CID000005516 |
| Drug | propoxyphene | 1.95e-10 | 67 | 88 | 8 | CID000010100 | |
| Drug | carteolol | 3.52e-10 | 72 | 88 | 8 | CID000002583 | |
| Drug | AC1Q7AUJ | CYP2A6 CYP2A7 CYP2A13 CYP2C19 CYP2C8 CYP2C9 UGT1A6 CYP27A1 CYP2U1 | 7.44e-10 | 117 | 88 | 9 | CID000003303 |
| Drug | trimipramine | 8.32e-10 | 80 | 88 | 8 | CID000005584 | |
| Drug | felodipine | CACNA1E CYP2A6 CYP2A7 CYP2A13 CYP2C19 CYP2C8 CYP2C9 CYP27A1 CYP2U1 ITPR1 | 1.07e-09 | 169 | 88 | 10 | CID000003333 |
| Drug | hexobarbital | CYP2A6 CYP2A7 CYP2A13 CYP2C19 CYP2C8 CYP2C9 UGT1A6 CYP27A1 CYP2U1 | 1.55e-09 | 127 | 88 | 9 | CID000003608 |
| Drug | mephenytoin | 1.80e-09 | 88 | 88 | 8 | CID000004060 | |
| Drug | BP-7,8-oxide | 2.34e-09 | 32 | 88 | 6 | CID000037455 | |
| Drug | tienilic acid | 2.80e-09 | 93 | 88 | 8 | CID000038409 | |
| Drug | lansoprazole | 2.80e-09 | 93 | 88 | 8 | CID000003883 | |
| Drug | 1-naphthol | 2.86e-09 | 33 | 88 | 6 | ctd:C029350 | |
| Drug | tolbutamide | CYP2A6 CYP2A7 CYP2A13 CYP2C19 CYP2C8 CYP2C9 AGL CYP27A1 CYP2U1 AKT2 | 4.94e-09 | 198 | 88 | 10 | CID000005505 |
| Drug | Sparteinum | 5.43e-09 | 101 | 88 | 8 | CID000003966 | |
| Drug | N-NK | BLMH CYP2A6 CYP2A7 CYP2A13 CYP2C19 CYP2C8 CYP2C9 UGT1A6 CHRNA1 | 5.99e-09 | 148 | 88 | 9 | CID000047289 |
| Drug | D 703 | 6.33e-09 | 18 | 88 | 5 | CID000054088 | |
| Drug | diclofenac | PDS5B CYP2A6 CYP2A7 CYP2A13 CYP2C19 CYP2C8 CYP2C9 UGT1A6 CYP27A1 CYP2U1 | 8.29e-09 | 209 | 88 | 10 | CID000003032 |
| Drug | 1h1q | 9.95e-09 | 70 | 88 | 7 | CID000001540 | |
| Drug | paraoxon | CYP2A6 CYP2A7 CYP2A13 CYP2C19 CYP2C8 CYP2C9 CYP27A1 CYP2U1 CHRNA1 | 1.47e-08 | 164 | 88 | 9 | CID000009395 |
| Drug | polybrominated biphenyl | 1.76e-08 | 44 | 88 | 6 | CID000042948 | |
| Drug | 8-MOP | 1.86e-08 | 118 | 88 | 8 | CID000004114 | |
| Drug | azoline | 1.92e-08 | 22 | 88 | 5 | CID003013050 | |
| Drug | benzphetamine | 1.99e-08 | 119 | 88 | 8 | CID000002341 | |
| Drug | aminopyrine | CYP2A6 CYP2A7 CYP2A13 CYP2C19 CYP2C8 CYP2C9 UGT1A6 CYP27A1 CYP2U1 | 2.12e-08 | 171 | 88 | 9 | CID000006009 |
| Drug | Tryptamines | 2.59e-08 | 9 | 88 | 4 | ctd:D014363 | |
| Drug | 5-chlorotryptamine | 2.59e-08 | 9 | 88 | 4 | ctd:C529169 | |
| Drug | 19-HETE | 3.43e-08 | 49 | 88 | 6 | CID006439528 | |
| Drug | halothane | CACNA1E CYP2A6 CYP2A7 CYP2A13 CYP2C19 CYP2C8 CYP2C9 CYP27A1 CYP2U1 CHRNA1 ITPR1 | 3.59e-08 | 314 | 88 | 11 | CID000003562 |
| Drug | chloral hydrate | 3.75e-08 | 129 | 88 | 8 | CID000002707 | |
| Drug | methylpropylnitrosamine | 3.84e-08 | 25 | 88 | 5 | CID000013545 | |
| Drug | Tranylcypromine | 3.84e-08 | 25 | 88 | 5 | ctd:D014191 | |
| Drug | 6-hydroxymelatonin | 3.89e-08 | 50 | 88 | 6 | CID000001864 | |
| Drug | 2'-methoxyacetophenone | 5.58e-08 | 3 | 88 | 3 | CID000068481 | |
| Drug | BP-9,10-oxide | 5.80e-08 | 27 | 88 | 5 | CID000037456 | |
| Drug | Brn 4136738 | 5.80e-08 | 27 | 88 | 5 | CID000050331 | |
| Drug | C14845 | 5.80e-08 | 27 | 88 | 5 | CID011954064 | |
| Drug | trans-1,2-dihydro-1,2-naphthalenediol | 6.73e-08 | 11 | 88 | 4 | ctd:C507866 | |
| Drug | nifedipine | CACNA1E CYP2A6 CYP2A7 COL7A1 MYO3A CYP2A13 CYP2C19 CYP2C8 CYP2C9 CYP27A1 CYP2U1 ITPR1 | 6.76e-08 | 415 | 88 | 12 | CID000004485 |
| Drug | 9-OH-BaP-4,5-oxide | 7.04e-08 | 28 | 88 | 5 | CID000115064 | |
| Drug | aniline | 7.93e-08 | 142 | 88 | 8 | CID000006115 | |
| Drug | 7-hydroxy-4-trifluoromethylcoumarin | 8.49e-08 | 29 | 88 | 5 | CID005375667 | |
| Drug | bromobenzene | 9.80e-08 | 97 | 88 | 7 | CID000007961 | |
| Drug | 19-hydroxytestosterone | 1.02e-07 | 30 | 88 | 5 | CID000150968 | |
| Drug | 11-H-14,15-EETA | 1.02e-07 | 30 | 88 | 5 | CID011954058 | |
| Drug | PCB 77 | 1.05e-07 | 98 | 88 | 7 | CID000036187 | |
| Drug | BP-4,5-oxide | 1.31e-07 | 61 | 88 | 6 | CID000037786 | |
| Drug | 7-hydroxyquinoline | 1.45e-07 | 13 | 88 | 4 | CID000011378 | |
| Drug | 1'-hydroxymidazolam | 1.45e-07 | 13 | 88 | 4 | CID000107917 | |
| Drug | chlorzoxazone | 1.60e-07 | 63 | 88 | 6 | CID000002733 | |
| Drug | 12(13)-EpOME | 1.96e-07 | 34 | 88 | 5 | CID000001416 | |
| Drug | TCEO | 1.96e-07 | 34 | 88 | 5 | CID000028167 | |
| Drug | AC1O5XSP | 1.96e-07 | 34 | 88 | 5 | CID006442739 | |
| Drug | AC1L1CJI | 2.28e-07 | 35 | 88 | 5 | CID000001929 | |
| Drug | piperonyl butoxide | 2.32e-07 | 67 | 88 | 6 | CID000005794 | |
| Drug | caffeine | CACNA1E CYP2A6 CYP2A7 CYP2A13 CYP2C19 CYP2C8 CYP2C9 CYP27A1 CYP2U1 CNOT1 CHRNA1 RCC2 ITPR1 | 2.43e-07 | 562 | 88 | 13 | CID000002519 |
| Drug | 5,6-epoxyeicosatrienoic acid | 2.53e-07 | 68 | 88 | 6 | CID000001778 | |
| Drug | 15-H-11,12-EETA | 2.64e-07 | 36 | 88 | 5 | CID011954042 | |
| Drug | AC1L3NGJ | 2.64e-07 | 36 | 88 | 5 | CID000092121 | |
| Drug | 2'-(glutathion-S-yl)-deschlorodiclofenac | 2.75e-07 | 15 | 88 | 4 | ctd:C586542 | |
| Drug | 4-hydroxymephenytoin | 2.75e-07 | 15 | 88 | 4 | CID000119507 | |
| Drug | 8(9)-EET | 2.77e-07 | 69 | 88 | 6 | CID000001901 | |
| Drug | rifampicin | CYP2A6 CYP2A7 CYP2A13 CYP2C19 CYP2C8 CYP2C9 UGT1A6 CYP27A1 CYP2U1 CHST1 | 2.97e-07 | 306 | 88 | 10 | CID005381226 |
| Drug | 1-aminobenzotriazole | 3.28e-07 | 71 | 88 | 6 | CID000001367 | |
| Drug | 3 -hydroxypregn-5-en-20-one | CYP2A6 CYP2A7 CYP2A13 CYP2C19 CYP2C8 CYP2C9 UGT1A6 CYP27A1 CYP2U1 | 3.57e-07 | 238 | 88 | 9 | CID000001027 |
| Drug | HCFC-141b | 3.66e-07 | 16 | 88 | 4 | CID000015586 | |
| Drug | 6-hydroxychlorzoxazone | 3.66e-07 | 16 | 88 | 4 | CID000002734 | |
| Drug | 1-phenylazo-2-naphthol | 3.66e-07 | 16 | 88 | 4 | ctd:C024336 | |
| Drug | 2,2,2-trichloroethanol | 3.88e-07 | 73 | 88 | 6 | CID000008259 | |
| Drug | 11,14,15-THET | 3.99e-07 | 39 | 88 | 5 | CID006439531 | |
| Drug | 7-hydroxycoumarin | 4.56e-07 | 75 | 88 | 6 | CID005281426 | |
| Drug | debrisoquine | 4.56e-07 | 75 | 88 | 6 | CID000002965 | |
| Drug | metyrapone | 4.69e-07 | 179 | 88 | 8 | CID000004174 | |
| Drug | N-benzylformamide | 4.94e-07 | 76 | 88 | 6 | CID000080654 | |
| Drug | furafylline | 5.16e-07 | 41 | 88 | 5 | CID000003433 | |
| Drug | bufuralol | 5.55e-07 | 5 | 88 | 3 | ctd:C010831 | |
| Drug | C20H32O4 | 5.76e-07 | 78 | 88 | 6 | CID000001440 | |
| Drug | BP-7,8-diol | 5.76e-07 | 78 | 88 | 6 | CID000025892 | |
| Drug | 11,12,15-trihydroxyeicosatrienoic acid | 5.84e-07 | 42 | 88 | 5 | CID006439610 | |
| Drug | L 654969 | 5.84e-07 | 42 | 88 | 5 | CID000005218 | |
| Drug | 7-benzyloxyquinoline | 6.12e-07 | 18 | 88 | 4 | CID003035604 | |
| Drug | 2,4-oxazolidinedione | 6.12e-07 | 18 | 88 | 4 | CID000097389 | |
| Drug | sulfaphenazole | 7.41e-07 | 44 | 88 | 5 | CID000005335 | |
| Drug | hydroxytolbutamide | 7.72e-07 | 19 | 88 | 4 | CID000003656 | |
| Drug | 6|A-Hydroxycortisol | 7.72e-07 | 19 | 88 | 4 | CID000150985 | |
| Drug | D 617 | 7.72e-07 | 19 | 88 | 4 | CID000093168 | |
| Drug | alprazolam | 8.30e-07 | 193 | 88 | 8 | CID000002118 | |
| Drug | naphthalene-1,2-dihydrodiol | 8.32e-07 | 45 | 88 | 5 | CID000000362 | |
| Drug | deferoxamine | CYP2A6 CYP2A7 CYP2A13 CYP2C19 CYP2C8 CYP2C9 CYP27A1 CYP2U1 MAPK6 RRM2 | 8.42e-07 | 343 | 88 | 10 | CID000002973 |
| Drug | bufuralol | 9.30e-07 | 46 | 88 | 5 | CID000071733 | |
| Drug | N'-nitrosoanatabine | 9.63e-07 | 20 | 88 | 4 | CID000051291 | |
| Drug | 3C etc | 9.63e-07 | 20 | 88 | 4 | CID000164045 | |
| Drug | tamoxifen N-oxide | 9.63e-07 | 20 | 88 | 4 | CID003033895 | |
| Drug | 3-methoxymorphinan | 9.63e-07 | 20 | 88 | 4 | CID000001671 | |
| Drug | AC1Q6O8T | 9.69e-07 | 197 | 88 | 8 | CID000002193 | |
| Drug | C14802 | 1.04e-06 | 47 | 88 | 5 | CID011954053 | |
| Drug | beta-naphthoflavone | 1.09e-06 | 200 | 88 | 8 | CID000002361 | |
| Drug | 4,4'-cyclohexylidenebisphenol | 1.11e-06 | 6 | 88 | 3 | ctd:C570106 | |
| Drug | 4',5-dihydroxydiclofenac | 1.11e-06 | 6 | 88 | 3 | CID003052567 | |
| Disease | 1,5 anhydroglucitol measurement | 1.98e-08 | 29 | 85 | 5 | EFO_0008009 | |
| Disease | neutrophil count, basophil count | 2.83e-07 | 224 | 85 | 8 | EFO_0004833, EFO_0005090 | |
| Disease | visceral adipose tissue measurement, body mass index | 5.40e-06 | 87 | 85 | 5 | EFO_0004340, EFO_0004765 | |
| Disease | Anoxic Encephalopathy | 8.20e-06 | 2 | 85 | 2 | C0003132 | |
| Disease | Brain Hypoxia | 8.20e-06 | 2 | 85 | 2 | C1527348 | |
| Disease | Anoxia of brain | 8.20e-06 | 2 | 85 | 2 | C0995195 | |
| Disease | Hypoxic Brain Damage | 8.20e-06 | 2 | 85 | 2 | C1140716 | |
| Disease | X-21258 measurement | 2.46e-05 | 3 | 85 | 2 | EFO_0800802 | |
| Disease | COUMARIN RESISTANCE | 2.46e-05 | 3 | 85 | 2 | 122700 | |
| Disease | Warfarin response | 2.46e-05 | 3 | 85 | 2 | cv:C0750384 | |
| Disease | Colorectal Carcinoma | CYP2A6 LIG3 COL7A1 GDAP1L1 ZKSCAN3 MCF2L2 RRM2 SPAG17 ADAMTSL3 ABCA9 | 3.42e-05 | 702 | 85 | 10 | C0009402 |
| Disease | pulse pressure measurement | LIG3 CYP2C9 LCA5L PRKAG1 PCDHA10 PCDHA7 UNC13D PCDHA5 PCDHA3 PCDHA2 ADAMTSL3 YY1 CNOT1 CDKAL1 | 4.16e-05 | 1392 | 85 | 14 | EFO_0005763 |
| Disease | Coumarin Resistance | 4.90e-05 | 4 | 85 | 2 | C0750384 | |
| Disease | post-traumatic stress disorder symptom measurement | 9.45e-05 | 82 | 85 | 4 | EFO_0008535 | |
| Disease | metabolite measurement | 2.14e-04 | 560 | 85 | 8 | EFO_0004725 | |
| Disease | hypoglycemia (is_implicated_in) | 2.27e-04 | 8 | 85 | 2 | DOID:9993 (is_implicated_in) | |
| Disease | neuroticism measurement, cognitive function measurement | 2.30e-04 | 566 | 85 | 8 | EFO_0007660, EFO_0008354 | |
| Disease | X-11308 measurement | 4.44e-04 | 11 | 85 | 2 | EFO_0800693 | |
| Disease | acute insulin response measurement | 4.44e-04 | 11 | 85 | 2 | EFO_0006831 | |
| Disease | autosomal dominant cerebellar ataxia (implicated_via_orthology) | 5.31e-04 | 12 | 85 | 2 | DOID:1441 (implicated_via_orthology) | |
| Disease | nicotine metabolite ratio | 5.31e-04 | 12 | 85 | 2 | EFO_0007794 | |
| Disease | thymol sulfate measurement | 5.31e-04 | 12 | 85 | 2 | EFO_0021170 | |
| Disease | peak insulin response measurement | 6.27e-04 | 13 | 85 | 2 | EFO_0008000 | |
| Disease | alkaline phosphatase measurement | CYP2A6 CYP2A7 MYO3A DCDC2 CYP2C9 EIF4G3 KIF17 CNOT1 ITPR1 PDCD1LG2 | 6.72e-04 | 1015 | 85 | 10 | EFO_0004533 |
| Disease | unipolar depression | CACNA1E DCDC2 ZKSCAN3 UNC13D PCDHA5 PCDHA3 PCDHA2 EIF4G3 CDKAL1 ACSS3 ITPR2 | 6.79e-04 | 1206 | 85 | 11 | EFO_0003761 |
| Disease | N-acetylmethionine measurement | 8.40e-04 | 15 | 85 | 2 | EFO_0021427 | |
| Disease | 16a-hydroxy DHEA 3-sulfate measurement | 8.40e-04 | 15 | 85 | 2 | EFO_0800301 | |
| Disease | andro steroid monosulfate C19H28O6S (1) measurement | 9.59e-04 | 16 | 85 | 2 | EFO_0800305 | |
| Disease | serum hepcidin measurement | 1.22e-03 | 18 | 85 | 2 | EFO_0004504 | |
| Disease | Colorectal Neoplasms | 1.25e-03 | 277 | 85 | 5 | C0009404 | |
| Disease | caffeine metabolite measurement | 1.36e-03 | 19 | 85 | 2 | EFO_0007872 | |
| Disease | depressive symptom measurement | 1.46e-03 | 426 | 85 | 6 | EFO_0007006 | |
| Disease | Drug toxicity | 1.86e-03 | 84 | 85 | 3 | C0013221 | |
| Disease | Adverse reaction to drug | 1.86e-03 | 84 | 85 | 3 | C0041755 | |
| Disease | neutrophil count | CSNK1G1 EML6 MAGI3 PCDHA10 PCDHA7 PCDHA5 AKAP11 PCDHA3 PCDHA2 CDKAL1 ITPR2 | 2.03e-03 | 1382 | 85 | 11 | EFO_0004833 |
| Disease | S-6-hydroxywarfarin to S-warfarin ratio measurement | 2.12e-03 | 88 | 85 | 3 | EFO_0803332 | |
| Disease | systemic mastocytosis | 2.36e-03 | 25 | 85 | 2 | MONDO_0016586 | |
| Disease | C-reactive protein measurement | CYP2A6 CYP2A7 DNAH17 POC1B DOCK7 SMARCC2 CCDC168 MAPK6 EIF4G3 ITPR1 | 2.43e-03 | 1206 | 85 | 10 | EFO_0004458 |
| Disease | S-warfarin to R-warfarin ratio measurement | 2.64e-03 | 95 | 85 | 3 | EFO_0803331 | |
| Disease | post-traumatic stress disorder | 2.80e-03 | 202 | 85 | 4 | EFO_0001358 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EVIIAKDEVAHTVTE | 186 | P31751 | |
| EVHRLVVVDENDVVK | 296 | P54619 | |
| HIVLVQEEIREPMEA | 71 | A8MXV6 | |
| PELEVGKHVVLTEQE | 1011 | Q15878 | |
| PKVVEEQESRVHYTV | 1456 | P0C0L5 | |
| PEVEAKVHEEIDRVI | 321 | P11509 | |
| PHEVEKEVQRVVQEL | 591 | Q8IUA7 | |
| HPEVTAKVQEEIDHV | 316 | P10632 | |
| EEKLDIEAVVHPREV | 1301 | Q9UKA4 | |
| VTPEQALAHEEVKTR | 1116 | P46940 | |
| AAVVITEPEHTKERV | 81 | Q9P258 | |
| DPEEAIRHDVIVSIV | 361 | Q9NTI5 | |
| INTHILKVPETDEVE | 126 | Q9BQ51 | |
| DPEEAIRHDVIVTII | 371 | Q29RF7 | |
| EEVPVIIHRDNIISD | 96 | Q96MZ0 | |
| IVRVVTHDDCIPEVK | 1406 | Q14571 | |
| VEVIVDRPLQVFHVE | 106 | Q9Y5H9 | |
| DRPLQVFHVEVEVKD | 111 | Q9Y5H9 | |
| SSVVRPVEDHRQVVE | 36 | P02708 | |
| ERPLQVFHVDVEVKD | 111 | Q9UN72 | |
| DRPLQVFHVEVEVKD | 111 | Q9Y5H8 | |
| EEIAVKVVGEHVEVH | 86 | O14558 | |
| EESHVPVIEESLRVQ | 1141 | Q5TCQ9 | |
| VRVVTHEDCIPEVKI | 1416 | Q14643 | |
| EEKVPRTISSVVLEH | 51 | Q8TBE3 | |
| PITAHAEVEVVEEAK | 391 | Q9HCP0 | |
| TTEIEIIAPHKVVER | 201 | Q9H252 | |
| VITHVDEIMQQEVRP | 21 | Q86YR7 | |
| VHEEDRQELLSVIPV | 251 | Q16659 | |
| PTVEYKEVTQEVVRH | 1246 | Q92817 | |
| KEVTQEVVRHERSPE | 1251 | Q92817 | |
| IVEHTEPRVAESQEL | 341 | B2RXH2 | |
| KIIEVIHPERESNQE | 471 | O95447 | |
| RTPHPHEEKVETVEI | 331 | Q8TC44 | |
| EVIVDRPLQVFHVEV | 106 | Q9Y5H7 | |
| VERVLHNAQEVEKEP | 451 | P49916 | |
| VPSAKVEVVEERQAI | 366 | Q14764 | |
| RPLQVFHVDVEVKDI | 111 | Q9Y5I2 | |
| NPDVQEKVHEEIERV | 371 | Q7Z449 | |
| PEVEAKVHEEIDRVI | 321 | Q16696 | |
| HPEVTAKVQEEIERV | 316 | P33261 | |
| NVTHKEEIILTPIEV | 1981 | Q96N67 | |
| PQVVSEDIVKQVHRL | 131 | Q9UFH2 | |
| DRVVEVVEETIKGHS | 161 | Q5VV42 | |
| PEVEAKVHEEIDRVI | 321 | P20853 | |
| EIQEALHEEVVGVVP | 356 | Q02318 | |
| LEHVPQVKIEQAERA | 521 | Q494V2 | |
| EVVVDRKHVPEEVLA | 421 | Q13867 | |
| RKHVPEEVLAVLEQE | 426 | Q13867 | |
| IEKFVDTPRHVEVQV | 246 | Q96RQ3 | |
| DEVVVTNTIPHEVQK | 316 | O60256 | |
| VPVLRVSHAEEEERV | 2831 | Q02388 | |
| VHEVPLGKQVTEAVV | 1841 | Q6ZMW3 | |
| QTKERIVPEHDVSRI | 6241 | Q8NDH2 | |
| HPEVTAKVQEEIERV | 316 | P11712 | |
| EVVAEVVKAPQVVAE | 426 | O60832 | |
| SDEIPVEHQVLVKRI | 26 | Q969E2 | |
| EPRKIITVSVKEDVH | 711 | O43432 | |
| EVVNTEVKPVIHSRI | 111 | Q9UHG0 | |
| PKVVEEQESRVHYTV | 1456 | P0C0L4 | |
| VVPTFRNEIEIEEDH | 776 | Q02241 | |
| PVIQHDVEAEKQLIR | 396 | Q9P2E2 | |
| THRKVPIVVTLVDDE | 1291 | P0C091 | |
| DRFVIEVDTIPKHSI | 301 | Q8IVG5 | |
| SVVIIDDHPEVTVIE | 1656 | Q9Y520 | |
| EVPTALVEAHVRKVE | 706 | Q8TAQ2 | |
| RVHFLQSVVVKVEEP | 1051 | Q9NRC6 | |
| EQVKIQEVTEESPHQ | 996 | Q6Q759 | |
| TEEQVLEEIVKHVRQ | 611 | Q9H6R3 | |
| SHVAIKTVRVPEVND | 201 | O43916 | |
| AIERAVQELVHPVVD | 1396 | A5YKK6 | |
| RRTTEQHVPEVEVQV | 11 | Q9Y675 | |
| EEIEPEHEGRKVVVF | 386 | Q8NCJ5 | |
| VHKPSEERVREIIIN | 281 | P31350 | |
| VELHEIEVETIPVET | 21 | P25490 | |
| HPVAITVEVKQEEDI | 146 | O95073 | |
| VVDIPEELVEEHDIT | 186 | Q2M296 | |
| QKVEPRIVIVEEAAE | 996 | Q9P2E3 | |
| DHTPKTVEEVTVERN | 361 | Q07157 | |
| VQEHHPESREDVVVV | 111 | Q16670 | |
| VREQHPESGEEVVVL | 106 | Q9BRR0 | |
| EELHVERVNQMPVEV | 541 | P52739 | |
| KTEVQEEEVVATPVH | 286 | Q6NUN9 | |
| DRGHEIVVVVPEVNL | 51 | P19224 | |
| IHEVPVGTEKTRERI | 586 | Q8IY18 | |
| VVELPVTERQIEREH | 351 | Q9BXI6 | |
| RQKAVVRHTIPEEET | 156 | Q70J99 | |
| VVHVDPDILQAEEKI | 921 | Q8TEY7 | |
| SHVSPEKREENVIAV | 236 | P82987 | |
| DELVPHQISVVSEER | 661 | P35573 | |
| LRHETVKERQVEPVT | 1326 | Q8NEV4 |